¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pulse field electrophoresis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
  • complex receptive field
    º¹ÇÕ¼ö¿ë¾ß
  • comprehensive field irradiation
    ±¤¹üÀ§Á¶»ç
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°á¼Õ
  • dark field microscope
    ¾Ï½Ã¾ßÇö¹Ì°æ
  • dark field microscopy
    ¾Ï½Ã¾ßÇö¹Ì°æ°Ë»ç(¹ý)
  • dark-field illumination
    ¾Ï½Ã¾ßÁ¶¸í
  • diplopia field
    º¹½Ã½Ã¾ß, °ãº¸Àӽþß
  • electric field
    Àü±âÀå
  • electromagnetic field
    ÀüÀÚ±âÀå
  • field
    1. ºÐ¾ß, ¿µ¿ª, ¹üÀ§ 2. ºÎÀ§ 3. ½Ã¾ß 4. Àü±âÀå
  • field block
    ºÎÀ§Â÷´Ü
  • field defect
    ½Ã¾ß°á¼Õ
  • field inhomogeneity
    ÀÚÀåºÒ±ÕÁú¼º
  • field survey
    ÇöÁöÁ¶»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • static magnetic field
    Á¤ÀÚ±âÀå
  • visual field
    ½Ã¾ß
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
  • field block
    ºÎÀ§Â÷´Ü¸¶Ãë
  • complex receptive field
    º¹ÇÕ¼ö¿ë¾ß
  • comprehensive field irradiation
    ±¤¹üÀ§Á¶»ç
  • confrontation field test
    ´ë¸é½Ã¾ß°Ë»ç
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°áÇÔ
  • constant field equation
    Á¤ÀüÀ广Á¤½Ä
  • dark field microscope
    ¾Ï½Ã¾ßÇö¹Ì°æ
  • dark field microscopy
    ¾Ï½Ã¾ßÇö¹Ì°æ°Ë»ç
  • dark-field illumination
    ¾Ï½Ã¾ßÁ¶¸í
  • diplopia field
    º¹½Ã½Ã¾ß, °ãº¸Àӽþß
  • field defect
    ½Ã¾ß°á¼Õ
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • visual field defect
    ½Ã¾ß°á¼Õ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • geometrical field
    ±âÇÏÇÐÀûÁ¶»ç¿µ¿ª
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • gravitational field
    Áß·ÂÀå(ñìæ³íÞ).
  • high field MR scanner
    °íÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • illumination, dark-field
    ¾Ï½Ã¾ßÁ¶¸í
  • point outside field
    Á¶»ç¿µ¿ª¹ÛÁöÁ¡
  • radio-frequency field
    °íÁÖÆÄ ÀÚÀå
  • rectangular field of view (FOV)
    Á÷»ç°¢Çü ½Ã¾ß
  • relative field
    ºñ±³¿µ¿ª(ÝïÎòçÐæ´).
  • 90o pulse
    90o ÆÞ½º, 90o ÆÄ
  • Corrigans pulse
    ÄÚ¸®°£¸Æ.
  • FID pulse sequence
    ÀÚÀ¯ ºØ±« À¯µµ ÆÞ½º ¿¬¼â
  • Jugular pulse
    °æÁ¤¸Æ(Ìòð¡Øæ) ¸Æ¹Ú(ØæÚÑ)
  • RF pulse
    °íÁÖÆÄ ÆÞ½º
  • RF pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • isoelectric electrophoresis
    µîÀü¾ÐÀü±â¿µµ¿
  • moving boundary electrophoresis
    À̵¿°æ°èÀü±â¿µµ¿(ì¹ÔÑÌèÍ£ï³Ñ¨ç¶ÔÑÛö) .
  • moving boundary electrophoresis
    À̵¿ÇѰèÀü±â¿µµ¿¹ý
  • moving boundary electrophoresis
    À̵¿ÇѰèÀü±â¿µµ¿(¹ý)(ì¹ÔÑùÚÍ£ï³Ñ¨ç¶ÔÑÛö) .
  • paper electrophoresis
    ¿©ÁöÀü±â¿µµ¿¹ý(æ¤òµï³Ñ¨ç¶ÔÑÛö).
  • paper electrophoresis apparatus
    ¿©ÁöÀü±â¿µµ¿ÀåÄ¡(¡­íûöÇ).
  • starch block electrophoresis
    ³ì¸»ºí·ÏÀü±â¿µµ¿(¡­ï³Ñ¨ç¶ÔÑ).
  • starch gel electrophoresis
    ³ì¸»°ÖÀü±â¿µµ¿(¡­ï³Ñ¨ç¶ÔÑ).
  • zonal electrophoresis
    ´ëÀü±â¿µµ¿(¹ý)
  • zone electrophoresis
    ±¸¿ª Àü±â¿µµ¿(¹ý).
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, -¿µ¿ª, Á¢ÃËÁ¶»ç¸é
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • auditory field
    û¿ª, û¾ß
  • binocular field
    ¾ç¾È½Ã¾ß
  • blue-field entopic phenomenon
    û»ö½Ã¾ß³»½ÃÇö»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • field flow fractionation
    Àå(íÞ)È帧 ºÐȹ¹ý(ÝÂüñÛö)
  • field ionization mass spectrometry
    Àå(íÞ) ÀÌ¿ÂÈ­(ûù) Áú·®ºÐ±¤ÃøÁ¤¹ý(òõÕáÝÂÎÃö´ïÒÛö)
  • field ion microscope
    Àå(íÞ) À̿ Çö¹Ì°æ(úéÚ°Ìð)
  • ligand field theory
    ¸®°£µåÀå(íÞ) ÀÌ·Ð(ìµÖå)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • magnetic field
    ÀÚÀå(í¸íÞ)
  • sedimentation field flow fractionation
    ħ°­Àå(öØË½íÞ) È帧ºÐȹ¹ý(ÝÂüñÛö)
  • affinity electrophoresis
    ģȭÀü±â¿µµ¿ (öÑûúï³Ñ¨ç¶ÔÑ)
  • agar gel electrophoresis
    ÇÑõ(ùÎô¸)Á©Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • block electrophoresis
    ºí·Ï Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • cellulose acetate electrophoresis
    ¾Æ¼¼Æ®»ê(ß«)¼¿·ê·Î½º Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • cons electrophoresis
    "Äܽº Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ),"
  • continuous flow electrophoresis
    ¿¬¼Ó(ææáÙ)È帧 Àü±â¿µµ¿¹ý(ï³Ñ¨ç¶ÔÑÛö)
  • cross-electrophoresis
    ±³Â÷Àü±â¿µµ¿(Îßó©ï³Ñ¨ç¶ÔÑ)
  • crossing-paper electrophoresis
    "±³Â÷¿©Áö Àü±â¿µµ¿(Îß󩿤òµï³Ñ¨ç¶ÔÑ), (ÔÒ) cross-electro-phoresis"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • offset-resonance pulse
    ¿ÀÇÁ¼Â°ø¸íÆÞ½º
  • presaturation pulse
    ÀüÆ÷È­ÆÄµ¿
  • pulse
    ¸Æ, ¸Æ¹Ú, ÆÞ½º
  • pulse control unit
    ¸Æ¹ÚÁ¶Àý´ÜÀ§
  • pulse cycle
    ¸Æ¹ÚÁÖ±â
  • pulse echo principle
    ÆÞ½º¿¡ÄÚ¿ø¸®
  • pulse echo technique
    ÆÞ½º¿¡ÄÚ±â¹ý
  • pulse method
    ÆÞ½º¹ý
  • pulse pressure
    ¸Æ¾Ð
  • pulse rate
    ¸Æ¹Ú¼ö, ÆÞ½ºÀ²
  • pulse repetition
    ÆÞ½º¹Ýº¹
  • pulse repetition frequency
    ÆÞ½º¹Ýº¹Á֯ļö
  • pulse repetition period
    ÆÞ½º¹Ýº¹ÁÖ±â
  • pulse repetition rate
    ÆÞ½º¹Ýº¹À²
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PFG peak flow gauge; pulsed-field gel electrophoresis
PFGE pulsed field gel electrophoresis
B1 induced field in magnetic resonance imaging; radiofrequency magnetic field in nuclear magnetic reson...
EF ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e...
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DPASV Differential Pulse Anodic Stripping Voltammetry
DPP Differential Pulse Polarography
DNPV Differential normal pulse voltammetry
DPV Differential pulse voltammetry
OPA Ocular Pulse Amplitude
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hard pulse
    ÇÏµå ÆÞ½º, °æÆÄ
  • heat pulse
    ¿­ ÀÚ±Ø
  • hypodicrotic pulse
    ¾ÆÁß º¹¸Æ
  • inversion recovery pulse sequence
    ¿ªÀü ȸº¹ ÆÞ½º ¿¬¼â
  • jugular venous pulse
    °æÁ¤¸Æ ÆÄ
  • nail pulse
    ¼ÕÅé ¹Ù´Ú¸Æ, Á¶»ó¸Æ
  • noxious heat pulse
    À¯ÇØ ¿­ ÆÞ½º
  • paradoxic pulse
    ±â¸Æ
    ¸Æ¹ÚÀÌ ¾î¶² ¿øÀÎÀ¸·Î ÀÎÇØ ºÒ±ÔÄ¢ÀûÀ¸·Î ¶Ù´Â °Í.
  • peripheral pulse
    ¸»ÃÊ ¸Æ¹Ú
  • pulse control unit
    ¸Æ¹Ú Á¶Àý ´ÜÀ§
  • pulse cycle
    ¸Æ¹Ú ÁÖ±â
  • pulse echo principle
    ÆÞ½º ¿¡ÄÚ ¿ø¸®
  • pulse energy
    ÆÞ½º ¿¡³ÊÁö
  • pulse monitor
    ¸Æ¹Ú°è
  • pulse pressure
    ¸Æ¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
disc electrophoresis Short for discontinuous electrophoresis, it is a type of polyacrylamide gel electrophoresis. This electrophoresis method uses gels of two different concentrations of polyacrylamide (a synthetic polymer), the one of lower concentration stacked on top of the one with higher concentration, in order to better resolve bands of whatever is being separated (DNA, RNA, or protein) that would otherwise be very close together.
(09 Oct 1997)
immunoglobulin electrophoresis <immunology, investigation> A test that detects and measures the various immunoglobulins in the blood.
In the normal assay no monoclonal antibodies are detected but in multiple myeloma and chronic lymphocytic leukaemia a single clone of lymphocytes can produce one type of immunoglobulin that is detected in the electrophoresis as monoclonal (made by one cell clone).
(30 Mar 1998)
isoenzyme electrophoresis Electrophoretic separation of serum enzymes; separation of lactate dehydrogenase and creatine phosphokinase is commonly used for diagnosis of acute myocardial infarction.
(05 Mar 2000)
thin-layer electrophoresis Electrophoretic migrations (separations) through a thin layer of inert material, such as cellulose, supported on a glass or plastic plate.
(05 Mar 2000)
Tiselius electrophoresis cell The special container in a Tiselius apparatus containing the solution to be analyzed electrophoretically.
(05 Mar 2000)
electrophoresis <technique> Separation of ionic molecules, (principally proteins) by the differential migration through a gel according to the size and ionic charge of the molecules in an electrical field. High resolution techniques normally use a gel support for the fluid phase.
Examples of gels used are starch, acrylamide, agarose or mixtures of acrylamide and agarose. Frictional resistance produced by the support causes size, rather than charge alone, to become the major determinant of separation.
Smaller molecules with a more negative charge will travel faster and further through the gel toward the anode of an electrophoretic cell when high voltage is applied. Similar molecules will group on the gel. They may be visualised by staining and quantitated, in relative terms, using densitometers which continuously monitor the photometric density of the resulting stain.
The electrolyte may be continuous (a single buffer) or discontinuous, where a sample is stacked by means of a buffer discontinuity, before it enters the running gel/ running buffer. The gel may be a single concentration or gradient in which pore size decreases with migration distance.
In SDS gel electrophoresis of proteins or electrophoresis of polynucleotides, mobility depends primarily on size and is used to determined molecular weight. In pulse field electrophoresis, two fields are applied alternately at right angles to each other to minimise diffusion mediated spread of large linear polymers.
See: electrofocussing, pulse field electrophoresis
(01 Dec 1998)
electrophoresis, agar gel Electrophoresis in which agar or agarose gel is used as the diffusion medium.
(12 Dec 1998)
electrophoresis, capillary A highly-sensitive (in the picomolar range, which is 10,000-fold more sensitive than conventional electrophoresis) and efficient technique that allows separation of proteins, nucleic acids, and carbohydrates.
(12 Dec 1998)
electrophoresis, cellulose acetate Electrophoresis in which cellulose acetate is the diffusion medium.
(12 Dec 1998)
electrophoresis, disc Electrophoresis in which discontinuities in both the voltage and pH gradients are introduced by using buffers of different composition and pH in the different parts of the gel column. The term 'disc' was originally used as an abbreviation for 'discontinuous' referring to the buffers employed, and does not have anything to do with the shape of the separated zones.
(12 Dec 1998)
electrophoresis, gel, two-dimensional Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels.
(12 Dec 1998)
electrophoresis, paper Electrophoresis in which paper is used as the diffusion medium. This technique is confined almost entirely to separations of small molecules such as amino acids, peptides, and nucleotides, and relatively high voltages are nearly always used.
(12 Dec 1998)
electrophoresis, polyacrylamide gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.
(12 Dec 1998)
electrophoresis, starch gel Electrophoresis in which a starch gel (a mixture of amylose and amylopectin) is used as the diffusion medium.
(12 Dec 1998)
two dimensional gel electrophoresis <technique> A high resolution separation technique in which protein samples are separated by isoelectric focussing in one dimension and then laid on an SDS gel for size determined separation in the second dimension. Can resolve hundreds of components on a single gel.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Field Marshal
    À°±º ¿ø¼ö
  • Field prize
    Çʵå»ó
  • brick field
    º®µ¹°øÀå
  • center field
    ¼¾ÅÍ(ÀÇ ¼öºñÀ§Ä¡)
  • dark field
    (Çö¹Ì°æÀÇ) ¾Ï½Ã¾ß
  • dark field illumination
    ¾Ï½Ã¾ß Á¶¸í¹ý(Çö¹Ì°æ ½Ã·áÀÇ)
  • dark field microscope
    (±¤)ÇÑ¿Ü Çö¹Ì°æ;¾Ï½Ã¾ß Çö¹Ì°æ
  • electric field
    Àü°è
  • field
    µé;¹úÆÇ;¹ç;±¤Àå;Ç¥¸é;»êÁö;½Î¿òÅÍ;°æ±âÀå;³»(¿Ü)¾ß;ºÐ¾ß;¹ÙÅÁ;¿µ»ó¸é(coal field źÀü)
  • field allowance
    ÃâÁ¤ ¼ö´ç
  • field amvulance
    À̵¿¾ßÀüº´¿ø
  • field army
    ¾ßÀü±º
  • field artillery
    ¾ßÆ÷;¾ßÀüÆ÷º´
  • field bag
    =MUSETTE (BAG)
  • field battery
    ¾ßÆ÷´ë;¾ßÀüÆ÷º´ Áß´ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á